These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 2201922

  • 1. Suppression of c-ras transformation by GTPase-activating protein.
    Zhang K, DeClue JE, Vass WC, Papageorge AG, McCormick F, Lowy DR.
    Nature; 1990 Aug 23; 346(6286):754-6. PubMed ID: 2201922
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Regulation of the Ras signaling pathway by GTPase-activating protein in PC12 cells.
    Yao R, Cooper GM.
    Oncogene; 1995 Oct 19; 11(8):1607-14. PubMed ID: 7478585
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ras-GTPase activating protein inhibition specifically induces apoptosis of tumour cells.
    Leblanc V, Delumeau I, Tocqué B.
    Oncogene; 1999 Aug 26; 18(34):4884-9. PubMed ID: 10490822
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA.
    Anticancer Res; 1985 Aug 26; 5(5):485-98. PubMed ID: 3904595
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Transforming and c-fos promoter/enhancer-stimulating activities of a GDP/GTP exchange protein for small GTP-binding proteins.
    Takai Y, Kaibuchi K, Kikuchi A, Kawata M, Sasaki T, Yamamoto T.
    Princess Takamatsu Symp; 1991 Aug 26; 22():197-204. PubMed ID: 1844241
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ras interaction with the GTPase-activating protein (GAP).
    Schaber MD, Garsky VM, Boylan D, Hill WS, Scolnick EM, Marshall MS, Sigal IS, Gibbs JB.
    Proteins; 1989 Aug 26; 6(3):306-15. PubMed ID: 2516318
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differences in GTPase-activating protein activity between liver tumors and normal liver tissue in mice.
    Müller O, Frech M, Gideon P, Wittinghofer A, Schwarz M.
    Oncogene; 1992 Jul 26; 7(7):1407-12. PubMed ID: 1620552
    [Abstract] [Full Text] [Related]

  • 19. Decreased GTPase activity of K-ras mutants deriving from human functional adrenocortical tumours.
    Lin SR, Hsu CH, Tsai JH, Wang JY, Hsieh TJ, Wu CH.
    Br J Cancer; 2000 Mar 26; 82(5):1035-40. PubMed ID: 10737386
    [Abstract] [Full Text] [Related]

  • 20. Complex formation between the p21ras GTPase-activating protein and phosphoproteins p62 and p190 is independent of p21ras signalling.
    Pronk GJ, de Vries-Smits AM, Ellis C, Bos JL.
    Oncogene; 1993 Oct 26; 8(10):2773-80. PubMed ID: 8378086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.